Advanced search
Add to list

Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics

(2018) CEPHALALGIA. 38(suppl. 1). p.151-151
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Vandervorst, F., et al. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : An Overview of Available Results and Comparison with the Currently Used Prophylactics.” CEPHALALGIA, vol. 38, no. suppl. 1, 2018, pp. 151–151.
APA
Vandervorst, F., Van Deun, L., De Keyser, J., Paemeleire, K., & Versijpt, J. (2018). Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics. In CEPHALALGIA (Vol. 38, pp. 151–151). London, UK.
Chicago author-date
Vandervorst, F., Laura Van Deun, Jacques De Keyser, Koen Paemeleire, and Jan Versijpt. 2018. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : An Overview of Available Results and Comparison with the Currently Used Prophylactics.” In CEPHALALGIA, 38:151–151.
Chicago author-date (all authors)
Vandervorst, F., Laura Van Deun, Jacques De Keyser, Koen Paemeleire, and Jan Versijpt. 2018. “Anti-CGRP Monoclonal Antibodies for the Treatment of Episodic Migraine : An Overview of Available Results and Comparison with the Currently Used Prophylactics.” In CEPHALALGIA, 38:151–151.
Vancouver
1.
Vandervorst F, Van Deun L, De Keyser J, Paemeleire K, Versijpt J. Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics. In: CEPHALALGIA. 2018. p. 151–151.
IEEE
[1]
F. Vandervorst, L. Van Deun, J. De Keyser, K. Paemeleire, and J. Versijpt, “Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics,” in CEPHALALGIA, London, UK, 2018, vol. 38, no. suppl. 1, pp. 151–151.
@inproceedings{8598753,
  articleno    = {{abstract MTIS2018-1}},
  author       = {{Vandervorst, F. and Van Deun, Laura and De Keyser, Jacques and Paemeleire, Koen and Versijpt, Jan}},
  booktitle    = {{CEPHALALGIA}},
  issn         = {{0333-1024}},
  language     = {{eng}},
  location     = {{London, UK}},
  number       = {{suppl. 1}},
  pages        = {{abstract MTIS2018-1:151--abstract MTIS2018-1:151}},
  title        = {{Anti-CGRP monoclonal antibodies for the treatment of episodic migraine : an overview of available results and comparison with the currently used prophylactics}},
  volume       = {{38}},
  year         = {{2018}},
}

Web of Science
Times cited: